Qi Xiaolong

Qi Xiaolong

Qi Xiaolong, professor, doctoral supervisor, selected into the National High-Level Talent Program, assistant to the president of Zhongda Hospital Affiliated to Southeast University, director of the Center for Portal Hypertension; founder of CHESS, chairman of the alliance; founder of PH&C, editor-in-chief of the journal; chairman of the Portal Hypertension Alliance of the National Center for Infectious Diseases; Chairman of the Portal Hypertension Professional Committee of the Chinese Association for the Promotion of Human Health Science and Technology; Vice Chairman of the Portal Hypertension Outreach Committee of the American Society for the Study of the Liver.

He has long been committed to the research, development and transformation of new technologies for the diagnosis and treatment of portal hypertension in liver cirrhosis. A total of 168 SCI papers have been published, with an impact factor of 1950.849 points, 6384 citations, and H-index 41 (data updated on June 1, 2023). Main corresponding author papers: Lancet Gastroenterol Hepatol (45.042), J Hepatol (30.083), Gut (31.793), Radiology (29.146), Cell Rep Med (16.988), Ann Surg (13.787), Clin Gastroenterol Hepatol (13.576), Am J Gastroenterol (12.045) .

He took the lead in formulating 3 consensus guidelines including the “China Expert Consensus on the Clinical Application of Hepatic Venous Pressure Gradient” and won the Asia-Pacific Association for the Study of the Liver (APASL) Rising Star Award (the only award-winning expert in China), DAMO Academy’s “Green Orange Outstanding Finalist Award”, and 2 first prizes in provincial and ministerial level Science and Technology Progress Awards.

Translated from the original Chinese source.

Tags :
Share :

Related Posts

Lu Jian

Lu Jian

Lu Jian, Ph.D. in Imaging Medicine and Nuclear Medicine, is an attending physician at the Interventional and Vascular Surgery Department of Zhongda Hospital Affiliated to Southeast University, a best young scholar at Southeast University, a postgraduate tutor at the School of Medicine, and a young and middle-aged academic leader in Jiangsu Province’s “333 High-Level Talent Training Project.” Selected into the National High-Level Talent Program. Focusing on innovative areas of tumor treatment such as radioactive particle stents and interventional surgical robots, the research results have been recommended by 7 domestic and foreign medical guidelines. Main research directions: intelligent diagnosis and treatment of major diseases, research and development of intelligent interventional devices, and clinical research on artificial intelligence.

Read More
Wan Zhuo

Wan Zhuo

Wan Zhuo, Ph.D., is a core member of the Jiangsu University Key Laboratory of Intelligent Medical Image Computing and the Intelligent Medical Research Institute. He received his bachelor’s and master’s degrees in computer science from Xi’an University of Architecture and Technology and the University of Warwick, UK, respectively, and received his PhD in computer science from the School of Computer Science, University of Warwick, UK. Currently, as the first author (including co-authors), he has published two SCI papers (SCI Area 1) and accepted one (SCI Area 1) in international journals in related fields, including Neuroimage (two articles, IF=6.5), a top journal in the field of neuroimaging, and EBioMedicine (one article, IF=8.2), a comprehensive sub-journal of The Lancet.

Read More
ABU BAKOR HAYAT ARNOB(Anon)

ABU BAKOR HAYAT ARNOB(Anon)

EDUCATION Nanjing University of Information Science and Technology, Major : Masters in Artificial Intelligence 2022-Current Huaian Institute of Technology, China Major : Bachelor in Software Engineering 2018-2022

Read More